{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:03:34Z","timestamp":1767171814284,"version":"build-2238731810"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We reported a rare case of indirect choroidal neovascularization (CNV) secondary to a posterior-segment intraocular foreign body (IOFB) that was not located in the area of direct injury but in the fovea. After intravitreal injections (IVIs) of aflibercept, the choroidal neovascularization (CNV) lesion disappeared and vision improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 26-year-old male patient suffered from a fast-shot metallic IOFB in his right eye. He underwent primary corneal repair, pars plana vitrectomy, IOFB removal and an IVI of antibiotics in the right eye. Two weeks later, cataract surgery was performed on the right eye for traumatic cataract after an episode of acute phacolytic glaucoma. The best-corrected visual acuity (BCVA) of the right eye improved to 20\/20 5 months after the first surgery. However, the vision of the right eye worsened suddenly with metamorphopsia 1 year after the first surgery. Color fundus images showed a whitish lesion with faint retinal hemorrhage and surrounding sensory elevation. Fluorescein angiography (FA) revealed a lesion with early- and late-phase severe leakage. Optical coherence tomography (OCT) demonstrated a CNV lesion with surrounding subretinal fluid. The patient received an IVI of aflibercept every 8\u2009weeks for 3 times. Finally, the BCVA of the right eye improved to 20\/25.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For rare cases of fovea-spared injury by a metallic IOFB, it is still necessary to pay close attention to the foveal microstructure to avoid possible CNV formation. Treatment with IVIs of anti-VEGF, aflibercept, as early as possible could provide good visual outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-020-01437-6","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T13:07:05Z","timestamp":1587474425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Indirect choroidal neovascularization secondary to a posterior-segment intraocular foreign body \u2013 case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu-Shiuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archopht.124.7.957","volume":"124","author":"CS Ament","year":"2006","unstructured":"Ament CS, Zacks DN, Lane AM, et al. Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol. 2006;124:957\u201366.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl. 1","key":"1437_CR2","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/00006982-199010001-00006","volume":"10","author":"DF Williams","year":"1990","unstructured":"Williams DF, Mieler WF, Williams GA. Posterior segment manifestations of ocular trauma. Retina. 1990;10(Suppl. 1):S35\u201344. https:\/\/doi.org\/10.1097\/00006982-199010001-00006.","journal-title":"Retina."},{"issue":"3","key":"1437_CR3","first-page":"290","volume":"8","author":"F Delori","year":"1969","unstructured":"Delori F, Pomerantzeff O, Cox MS. Deformation of the globe under high-speed impact: its relation to contusion injuries. Investig Ophthalmol. 1969;8(3):290\u2013301 PMID: 5772720.","journal-title":"Investig Ophthalmol"},{"key":"1437_CR4","first-page":"747","volume":"22","author":"D Kent","year":"2003","unstructured":"Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis. 2003;22:747\u201355.","journal-title":"Mol Vis"},{"key":"1437_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/ph11040112","volume":"11","author":"W Shu","year":"2018","unstructured":"Shu W, Dunaief JL. Potential Treatment of Retinal Diseases withIron Chelators. Pharmaceuticals. 2018;11:112. https:\/\/doi.org\/10.3390\/ph11040112.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"1437_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00006982-198101030-00013","volume":"1","author":"SS Shocket","year":"1981","unstructured":"Shocket SS, Lakhanpal V, Varma SD. Siderosis from a retained intraocular stone. Retina. 1981;1(3):201\u20137.","journal-title":"Retina"},{"key":"1437_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/TA.0b013e31817d7535","volume":"68","author":"TL Chen","year":"2010","unstructured":"Chen TL, Sun MH, Lin KK, Lai CC, Chen KJ. Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma. J Trauma. 2010;68:747.","journal-title":"J Trauma"},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2147\/OPTH.S62312","volume":"8","author":"E Fern\u00e1ndez-L\u00f3pez","year":"2014","unstructured":"Fern\u00e1ndez-L\u00f3pez E, Desco-Esteban MC, Fandi\u00f1o-L\u00f3pez A, Hern\u00e1ndez-D\u00edaz M, Navea A. Choroidal neovascularization after intraocular foreign body. Clin Ophthalmol. 2014;8:945\u20138.","journal-title":"Clin Ophthalmol"},{"key":"1437_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00417-009-1098-2","volume":"247","author":"F Liang","year":"2009","unstructured":"Liang F, Puche N, Soubrane G, Souied EH. Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture. Graefes Arch Clin Exp Ophthalmol. 2009;247:1285\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ajo.2014.05.025","volume":"158","author":"S Fauser","year":"2014","unstructured":"Fauser S, Schwabecker V, Muether PS. Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration. Am J Ophthalmol. 2014;158:532\u20136.","journal-title":"Am J Ophthalmol"}],"updated-by":[{"DOI":"10.1186\/s12886-020-01450-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000}}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01437-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01437-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01437-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T20:08:47Z","timestamp":1618949327000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01437-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01437-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We provided the patient with detailed information about all anti-VEGF drugs before treatment. The patient chose aflibercept, medication of off label use, and signed the consent form after fully understanding.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}